Influenza continues to pose a significant global threat, with seasonal outbreaks causing millions of infections, countless hospitalizations, economic disruptions, and approximately 290,000 to 650,000 annual deaths worldwide. Traditional flu vaccines, while criticalRead More…
Vaccines have transformed modern medicine, yet their impact hinges on a behind-the-scenes hero: analytical development. This process ensures every dose meets strict safety and efficacy benchmarks, from early design to global distribution.Read More…
The primary foundation of modern public health vaccination strategies depends on inactivated vaccines which have shown reliable safety records and effective protection against infectious diseases. This guide examines the scientific foundation ofRead More…
Introduction Vaccines have transformed public health, limiting infectious disease spread and saving millions of lives worldwide. mRNA vaccines, by which medical science developed a method of vaccination without losing effectiveness, have made itRead More…
Vaccines are the most successful public health measure ever, halting the spread of infectious diseases and slowing some of the worst disease ever seen in the vast majority of the world. AsRead More…
mRNA vaccines are one of the best medical and immunological discoveries of the past few years. While vaccines themselves aren’t exactly new, mRNA technology flips the script on how we think about immunization.Read More…
Researchers from the U.S. Army Medical Research Institute of Infectious Diseases and Moderna published a research paper titled “Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhumanRead More…
The team of Professor Michael J. Mitchell of the University of Pennsylvania and Professor Drew Weissman, winner of the 2023 Nobel Prize in Physiology and Medicine, published a review paper titled “EnhancingRead More…
Recently, the journal Nature Biomedical Engineering published a research paper titled “Dendritic-cell-targeting virus-like particles as latent mRNA vaccine carriers” about a new vaccine platform technology that can specifically target dendritic cells (DCs)Read More…
In a first-of-its-kind human clinical trial involving four adult patients, an mRNA cancer vaccine developed by the University of Florida rapidly reprograms the immune system to attack glioblastoma, the most aggressive andRead More…